Department of Radiation Oncology, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Shanghai, 200032, People's Republic of China.
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, People's Republic of China.
World J Surg Oncol. 2022 Sep 23;20(1):304. doi: 10.1186/s12957-022-02773-1.
Tumor deposits (TDs) have been identified as an independent prognostic factor in gastric cancer (GC). However, the associated clinicopathological factors and how to simply and reasonably incorporate TD into the TNM staging system remain undetermined. The aim of the current study was therefore to assess the significance of TD among radically resected GC patients.
We retrospectively reviewed 1915 patients undergoing radical resection between 2007 and 2012. The patients were classified into two groups according to TD status (absent vs. present), and the clinicopathologic characteristics, DFS, and OS were compared. Associations of TD presence with other clinicopathologic factors were evaluated by logistic regression analysis. Univariate and multivariate Cox regression analyses were performed to determine the prognostic factors for DFS and OS in the primary cohort. Propensity score matching (PSM) was performed to reduce the possibility of selection bias according to the presence of TD. External validation of previously proposed modified staging systems incorporating TD was conducted.
The detection rate of TD was 10.5% (201/1915). The presence of TD was significantly related to unfavorable clinicopathologic variables, including advanced T and N categories. According to the multivariate Cox regression analysis, the presence of TD was identified as an independent prognostic factor for DFS and OS in the primary cohort (both P < 0.001). In the after-PSM cohort, TD presence also significantly shortened DFS and OS. In the external validation, one system that incorporated TD into the pTNM stage had the best performance.
The presence of TD was significantly associated with poor survival in radically resected GC patients. The incorporation of TD into the TNM staging system can further improve the predictive capability. A multicenter cohort with a large sample size is needed to determine the appropriate method of incorporation.
肿瘤沉积物(TDs)已被确定为胃癌(GC)的独立预后因素。然而,相关的临床病理因素以及如何简单合理地将 TD 纳入 TNM 分期系统仍未确定。因此,本研究旨在评估 TD 在根治性切除的 GC 患者中的意义。
我们回顾性分析了 2007 年至 2012 年间接受根治性切除的 1915 例患者。根据 TD 状态(无 vs. 有)将患者分为两组,并比较了临床病理特征、DFS 和 OS。通过逻辑回归分析评估 TD 存在与其他临床病理因素的相关性。在主要队列中,进行单因素和多因素 Cox 回归分析以确定 DFS 和 OS 的预后因素。根据 TD 的存在进行倾向评分匹配(PSM),以降低选择偏倚的可能性。对包含 TD 的改良分期系统的外部验证。
TD 的检出率为 10.5%(201/1915)。TD 的存在与不利的临床病理变量显著相关,包括较晚的 T 和 N 分期。根据多因素 Cox 回归分析,TD 的存在是原发性队列中 DFS 和 OS 的独立预后因素(均 P<0.001)。在 PSM 后队列中,TD 的存在也显著缩短了 DFS 和 OS。在外部验证中,将 TD 纳入 pTNM 分期的一个系统表现最佳。
TD 的存在与根治性切除的 GC 患者的不良生存显著相关。将 TD 纳入 TNM 分期系统可以进一步提高预测能力。需要一个多中心、大样本量的队列来确定适当的纳入方法。